
Bioorganic and Medicinal Chemistry p. 731 - 737 (1997)
Update date:2022-08-04
Topics:
Angeli
Brasili
Cingolani
Marucci
Piergentili
Pigini
Quaglia
To develop ligands that may be useful in exploring muscarinic receptor heterogeneity, we synthesized a series of analogues of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine oxalate and methiodide bearing a modified cationic head. These compounds, when tested on tissues containing the three subtypes M1, M2, and M3, behaved as muscarinic antagonists whose results showed that different substituents on the quaternary and tertiary nitrogen affect affinity and selectivity in different ways. In particular, comparison of the affinities of these ligands with those of the reference compounds points out that compounds bearing an ethyl substituent improve the affinity of the molecule at the three subtypes, while compounds bearing a phenethyl substituent are more selective for the M3 sites.
View MoreNeostar United Industrial Co., Ltd.
Contact:0519-85557386
Address:Yangtze River North Road, Binjiang Economic Development Zone
Contact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Landz International Company Ltd.
Contact:0086-21-58891610
Address:985 Dongfang Road, Pudong, Shanghai 200122 China
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Chengdu Pukang Biotechnology Co., Ltd
website:http://www.pu-kang.com
Contact:86-028-63976226
Address:No. 868 Xiwang Road,Xinjin county,Chengdu city, China
Doi:10.1016/S0040-4039(00)72081-8
(1975)Doi:10.1248/cpb.26.1511
(1978)Doi:10.1002/anie.201809051
(2018)Doi:10.1002/j.2050-0416.2001.tb00089.x
(1937)Doi:10.1021/acsmedchemlett.9b00071
(2019)Doi:10.1039/a701770g
(1997)